Drosophila melanogaster as a model host for the Burkholderia cepacia complex

PLoS ONE

Volumn 5, Issue 7, 2010, Pages

  Castonguay Vanier, Josée ^a   Vial, Ludovic ^a   Tremblay, Julien ^a   Déziel, Eric ^a  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA INFECTION; CONTROLLED STUDY; DISEASE MODEL; DROSOPHILA MELANOGASTER; HOST PATHOGEN INTERACTION; MORTALITY; NONHUMAN; SENSITIVITY ANALYSIS; VALIDITY; ANIMAL; GENETICS; MICROBIOLOGY; PHYSIOLOGY; VIRULENCE;

BACTERIA (MICROORGANISMS); BURKHOLDERIA CEPACIA COMPLEX; DROSOPHILA MELANOGASTER; MAMMALIA; MURINAE; VERTEBRATA;

ANIMALS; BURKHOLDERIA CEPACIA COMPLEX; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; VIRULENCE;

EID: 77955409156     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011467     Document Type: Article

References (66)

1. Burkholder W (1950) Sour skin, a bacterial rot of onion bulbs. Phytopathology 64: 468-475.
2. Chiarini L, Bevivino A, Dalmastri C, Tabacchioni S, Visca P (2006) Burkholderia cepacia complex species: health hazards and biotechnological potential. Trends Microbiol 14: 277-286.
3. Vial L, Groleau MC, Dekimpe V, Déziel E (2007) Burkholderia diversity and versatility: an inventory of the extracellular products. J Microbiol Biotechnol 17: 1407-1429.
4. Aaron SD, Ferris W, Henry DA, Speert DP, Macdonald NE (2000) Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia. Am J Respir Crit Care Med 161: 1206-1212.
5. Weber DJ, Rutala WA, Sickbert-Bennett EE (2007) Outbreaks associated with contaminated antiseptics and disinfectants. Antimicrob Agents Chemother 51: 4217-4224.
6. Martin DW, Mohr CD (2000) Invasion and intracellular survival of Burkholderia cepacia. Infect Immun 68: 24-29.
7. Lamothe J, Huynh KK, Grinstein S, Valvano MA (2007) Intracellular survival of Burkholderia cenocepacia in macrophages is associated with a delay in the maturation of bacteria-containing vacuoles. Cell Microbiol 9: 40-53.
8. Marolda CL, Hauroder B, John MA, Michel R, Valvano MA (1999) Intracellular survival and saprophytic growth of isolates from the Burkholderia cepacia complex in free-living amoebae. Microbiology 145 (Pt7): 1509-1517.
9. Coenye T, Vandamme P, Govan JR, LiPuma JJ (2001) Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol 39: 3427-3436.
10. McClean S, Callaghan M (2009) Burkholderia cepacia complex: epithelial cell-pathogen confrontations and potential for therapeutic intervention. J Med Microbiol 58: 1-12.
11. Mahenthiralingam E, Baldwin A, Dowson CG (2008) Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology. J Appl Microbiol 104: 1539-1551.
12. Vanlaere E, Lipuma JJ, Baldwin A, Henry D, De Brandt E, et al. (2008) Burkholderia latens sp. nov., Burkholderia diffusa sp. nov., Burkholderia arboris sp. nov., Burkholderia seminalis sp. nov. and Burkholderia metallica sp. nov., novel species within the Burkholderia cepacia complex. Int JSyst Evol Microbiol 58: 1580-1590.
13. Sajjan U, Thanassoulis G, Cherapanov V, Lu A, Sjolin C, et al. (2001) Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice. Infect Immun 69: 5138-5150.
14. Tomich M, Griffith A, Herfst CA, Burns JL, Mohr CD (2003) Attenuated virulence of a Burkholderia cepacia type III secretion mutant in a murine model of infection. Infect Immun 71: 1405-1415.
15. Sousa SA, Ulrich M, Bragonzi A, Burke M, Worlitzsch D, et al. (2007) Virulence of Burkholderia cepacia complex strains in gp91phox-/- mice. Cell Microbiol 9: 2817-2825.
16. Chu KK, Davidson DJ, Halsey TK, Chung JW, Speert DP (2002) Differential persistence among genomovars of the Burkholderia cepacia complex in a murine model of pulmonary infection. Infect Immun 70: 2715-2720.
17. Seed KD, Dennis JJ (2008) Development of Galleria mellonella as an alternative infection model for the Burkholderia cepacia complex. Infect Immun 76: 1267-1275.
18. Bernier SP, Silo-Suh L, Woods DE, Ohman DE, Sokol PA (2003) Comparative analysis of plant and animal models for characterization of Burkholderia cepacia virulence. Infect Immun 71: 5306-5313.
19. Cardona ST, Wopperer J, Eberl L, Valvano MA (2005) Diverse pathogenicity of Burkholderia cepacia complex strains in the Caenorhabditis elegans host model. FEMS Microbiol Lett 250: 97-104.
20. Jander G, Rahme LG, Ausubel FM (2000) Positive correlation between virulence of Pseudomonas aeruginosa mutants in mice and insects. J Bacteriol 182: 3843-3845.
21. Markey KM, Glendinning KJ, Morgan JA, Hart CA, Winstanley C (2006) Caenorhabditis elegans killing assay as an infection model to study the role of type III secretion in Burkholderia cenocepacia. JMed Microbiol 55: 967-969.
22. Adams MD, Celniker SE, Holt RA, Evans CA, Gocayne JD, et al. (2000) The genome sequence of Drosophila melanogaster. Science 287: 2185-2195.
23. Fallon PG, Allen RL, Rich T (2001) Primitive Toll signalling: bugs, flies, worms and man. Trends Immunol 22: 63-66.
24. Medzhitov R, Preston-Hurlburt P, Janeway CA, Jr. (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397.
25. Hoffmann JA, Reichhart JM (2002) Drosophila innate immunity: an evolutionary perspective. Nat Immunol 3: 121-126.
26. Nicolas E, Reichhart JM, Hoffmann JA, Lemaitre B (1998) In vivo regulation of the IkappaB homologue cactus during the immune response of Drosophila. J Biol Chem 273: 10463-10469.
27. Apidianakis Y, Rahme LG, Heitman J, Ausubel FM, Calderwood SB, et al. (2004) Challenge of Drosophila melanogaster with Cryptococcus neoformans and role of the innate immune response. Eukaryot Cell 3: 413-419.
28. D'Argenio DA, Gallagher LA, Berg CA, Manoil C (2001) Drosophila as a model host for Pseudomonas aeruginosa infection. J Bacteriol 183: 1466-1471.
29. Chugani SA, Whiteley M, Lee KM, D'Argenio D, Manoil C, et al. (2001) QscR, a modulator of quorum-sensing signal synthesis and virulence in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 98: 2752-2757.
30. Lutter EI, Faria MM, Rabin HR, Storey DG (2008) Pseudomonas aeruginosa cystic fibrosis isolates from individual patients demonstrate a range of levels of lethality in two Drosophila melanogaster infection models. Infect Immun 76: 1877-1888.
31. Brummel T, Ching A, Seroude L, Simon AF, Benzer S (2004) Drosophila lifespan enhancement by exogenous bacteria. Proc Natl Acad Sci U S A 101: 12974-12979.
32. Roh SW, Nam YD, Chang HW, Kim KH, Kim MS, et al. (2008) Phylogenetic characterization of two novel commensal bacteria involved with innate immune homeostasis in Drosophila melanogaster. Appl Environ Microbiol 74: 6171-6177.
33. Cox CR, Gilmore MS (2007) Native microbial colonization of Drosophila melanogaster and its use as a model of Enterococcus faecalis pathogenesis. Infect Immun 75: 1565-1576.
34. Mahenthiralingam E, Vandamme P, Campbell ME, Henry DA, Gravelle AM, et al. (2001) Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans. Clin Infect Dis 33: 1469-1475.
35. Uehlinger S, Schwager S, Bernier SP, Riedel K, Nguyen DT, et al. (2009) Identification of Specific and Universal Virulence Factors in Burkholderia cenocepacia Strains by Using Multiple Infection Hosts. Infect Immun 77: 4102-4110.
36. Laws TR, Smith SA, Smith MP, Harding SV, Atkins TP, et al. (2005) The nematode Panagrellus redivivus is susceptible to killing by human pathogens at 37 degrees C. FEMS Microbiol Lett 250: 77-83.
37. Corbett CR, Burtnick MN, Kooi C, Woods DE, Sokol PA (2003) An extracellular zinc metalloprotease gene of Burkholderia cepacia. Microbiology 149: 2263-2271.
38. Kooi C, Subsin B, Chen R, Pohorelic B, Sokol PA (2006) Burkholderia cenocepacia ZmpB is a broad-specificity zinc metalloprotease involved in virulence. Infect Immun 74: 4083-4093.
39. Flannagan RS, Aubert D, Kooi C, Sokol PA, Valvano MA (2007) Burkholderia cenocepacia requires a periplasmic HtrA protease for growth under thermal and osmotic stress and for survival in vivo. Infect Immun 75: 1679-1689.
40. Loutet SA, Flannagan RS, Kooi C, Sokol PA, Valvano MA (2006) A complete lipopolysaccharide inner core oligosaccharide is required for resistance of Burkholderia cenocepacia to antimicrobial peptides and bacterial survival in vivo. J Bacteriol 188: 2073-2080.
41. Lewenza S, Conway B, Greenberg EP, Sokol PA (1999) Quorum sensing in Burkholderia cepacia: identification of the LuxRI homologs CepRI. J Bacteriol 181: 748-756.
42. Sokol PA, Sajjan U, Visser MB, Gingues S, Forstner J, et al. (2003) The CepIR quorum-sensing system contributes to the virulence of Burkholderia cenocepacia respiratory infections. Microbiology 149: 3649-3658.
43. Huber B, Feldmann F, Kothe M, Vandamme P, Wopperer J, et al. (2004) Identification of a novel virulence factor in Burkholderia cenocepacia H111 required for efficient slow killing of Caenorhabditis elegans. Infect Immun 72: 7220-7230.
44. Hunt TA, Kooi C, Sokol PA, Valvano MA (2004) Identification of Burkholderia cenocepacia genes required for bacterial survival in vivo. Infect Immun 72: 4010-4022.
45. Kukavica-Ibrulj I, Bragonzi A, Paroni M, Winstanley C, Sanschagrin F, et al. (2008) In vivo growth of Pseudomonas aeruginosa strains PAO1 and PA14 and the hypervirulent strain LESB58 in a rat model ofchronic lung infection. J Bacteriol 190: 2804-2813.
46. Riedel K, Arevalo-Ferro C, Reil G, Gorg A, Lottspeich F, et al. (2003) Analysis of the quorum-sensing regulon of the opportunistic pathogen Burkholderia cepacia H111 by proteomics. Electrophoresis 24: 740-750.
47. Mylonakis E, Aballay A (2005) Worms and flies as genetically tractable animal models to study host-pathogen interactions. Infect Immun 73: 3833-3841.
48. Brandt SM, Dionne MS, Khush RS, Pham LN, Vigdal TJ, et al. (2004) Secreted Bacterial Effectors and Host-Produced Eiger/TNF Drive Death in Salmonella-Infected Fruit Fly. PLoS Biol 2: e418.
49. Vodovar N, Acosta C, Lemaitre B, Boccard F (2004) Drosophila: a polyvalent model to decipher host-pathogen interactions. Trends Microbiol 12: 235-242.
50. Apidianakis Y, Mindrinos MN, Xiao W, Lau GW, Baldini RL, et al. (2005) Profiling early infection responses: Pseudomonas aeruginosa eludes host defenses by suppressing antimicrobial peptide gene expression. Proc Natl Acad Sci U S A 102: 2573-2578.
51. Fauvarque MO, Bergeret E, Chabert J, Dacheux D, Satre M, et al. (2002) Role and activation of type III secretion system genes in Pseudomonas aeruginosa-induced Drosophila killing. Microb Pathog 32: 287-295.
52. Sibley CD, Duan KM, Fischer C, Parkins MD, Storey DG, et al. (2008) Discerning the Complexity of Community Interactions Using a Drosophila Model of Polymicrobial Infections. Plos Pathogens 4(10): e1000184.
53. Elrod-Erickson M, Mishra S, Schneider D (2000) Interactions between the cellular and humoral immune responses in Drosophila. Current Biology 10: 781-784.
54. Nehme NT, Liegeois S, Kele B, Giammarinaro P, Pradel E, et al. (2007) A model of bacterial intestinal infections in Drosophila melanogaster. PLoS Pathog 3: e173.
55. Dionne MS, Ghori N, Schneider DS (2003) Drosophila melanogaster is a genetically tractable model host for Mycobacterium marinum. Infect Immun 71: 3540-3550.
56. Tzou P, Meister M, Lemaitre B (2002) Methods for studying infection and immunity in drosophila. In:Zychlinsky PSaA Methods in Microbiology. London: Academic Press. pp 507-529.
57. Vial L, Deziel E (2008) The fruit fly as a meeting place for microbes. Cell Host Microbe 4: 505-507.
58. Simon R, Priefer U, Puhler A (1983) A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram negative bacteria. Bio/Technology 1: 784-791.
59. Alexeyev MF (1999) The pKNOCK series of broad-host-range mobilizable suicide vectors for gene knockout and targeted DNA insertion into the chromosome of gram-negative bacteria. Biotechniques 26: 824-828.
60. Baldini RL, Lau GW, Rahme LG (2002) Use of plant and insect hosts to model bacterial pathogenesis. Methods Enzymol 358: 3-13.
61. Mahenthiralingam E, Coenye T, Chung JW, Speert DP, Govan JR, et al. (2000) Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. JClin Microbiol 38: 910-913.
62. Vandamme P, Holmes B, Coenye T, Goris J, Mahenthiralingam E, et al. (2003) Burkholderia cenocepacia sp. nov.-a new twist to an old story. Res Microbiol 154: 91-96.
63. Nelson MJ, Montgomery SO, Mahaffey WR, Pritchard PH (1987) Biodegra-dation of trichloroethylene and involvement of an aromatic biodegradative pathway. Appl Environ Microbiol 53: 949-954.
64. Coenye T, Vandamme P, LiPuma JJ, Govan JR, Mahenthiralingam E (2003) Updated version of the Burkholderia cepacia complex experimental strain panel. J Clin Microbiol 41: 2797-2798.
65. Vial L, Lepine F, Milot S, Groleau MC, Dekimpe V, et al. (2008) Burkholderia pseudomallei, B. thailandensis,andB. ambifaria produce 4-hydroxy-2-alkylquinoline analogues with a methyl group at the 3 position that is required for quorum-sensing regulation. JBacteriol 190: 5339-5352.
66. Coenye T, Mahenthiralingam E, Henry D, LiPuma JJ, Laevens S, et al. (2001) Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates. Int JSyst Evol Microbiol 51: 1481-1490.